Wellington Management Group’s Pardes Biosciences PRDS Stock Holding History
Bought
Maintained
Sold
Other funds holding PRDS
VS
LCM
Wellington Management Group's PRDS Position: Q2 2022 in Review
Wellington Management Group sold out of Pardes Biosciences (PRDS) in Q2 2022, closing a stake of 194,868 shares — an estimated $1.41M sold.
Wellington Management Group first reported a position in PRDS in Q4 2021 and held it in 2 quarters. The position peaked at $3.4M in Q4 2021. 69 funds tracked by Wall St. Rank hold PRDS as of Q2 2022.
- Wellington Management Group reported no remaining Pardes Biosciences position as of Q2 2022 after selling out during the quarter.
- Wellington Management Group sold 194,868 Pardes Biosciences shares in Q2 2022, an estimated $1.41M.
- Wellington Management Group first reported a position in Pardes Biosciences in Q4 2021 and held it in 2 quarters.
- Wellington Management Group's Pardes Biosciences position peaked at $3.4M in Q4 2021.
- 69 funds tracked by Wall St. Rank held Pardes Biosciences as of Q2 2022.
Based on Wellington Management Group's 13F filing for Q2 2022, filed 15 Aug 2022.